IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.564
AS - Asia 12.146
EU - Europa 9.200
SA - Sud America 2.319
AF - Africa 289
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 36
Totale 46.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.162
SG - Singapore 4.444
CN - Cina 4.036
IT - Italia 2.323
UA - Ucraina 2.032
BR - Brasile 1.930
HK - Hong Kong 1.464
DE - Germania 1.093
FR - Francia 709
VN - Vietnam 615
GB - Regno Unito 575
FI - Finlandia 545
TR - Turchia 455
RU - Federazione Russa 450
IE - Irlanda 392
PL - Polonia 391
IN - India 327
CA - Canada 199
SE - Svezia 148
BD - Bangladesh 147
AR - Argentina 138
MX - Messico 136
CZ - Repubblica Ceca 107
NL - Olanda 100
ZA - Sudafrica 94
IQ - Iraq 93
JP - Giappone 88
ID - Indonesia 81
EC - Ecuador 62
ES - Italia 61
SA - Arabia Saudita 59
BE - Belgio 52
CO - Colombia 51
AT - Austria 49
AU - Australia 47
PK - Pakistan 45
UZ - Uzbekistan 44
NG - Nigeria 42
VE - Venezuela 41
LT - Lituania 32
PY - Paraguay 32
IR - Iran 31
MA - Marocco 30
EU - Europa 29
EG - Egitto 25
CH - Svizzera 24
KE - Kenya 23
CL - Cile 22
PE - Perù 21
PH - Filippine 19
NP - Nepal 18
TN - Tunisia 18
ET - Etiopia 17
IL - Israele 17
JO - Giordania 17
AL - Albania 15
AZ - Azerbaigian 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
MY - Malesia 14
HU - Ungheria 13
PT - Portogallo 13
KR - Corea 12
RO - Romania 12
JM - Giamaica 11
UY - Uruguay 11
BG - Bulgaria 10
GR - Grecia 10
KG - Kirghizistan 10
KZ - Kazakistan 10
HN - Honduras 9
OM - Oman 9
PS - Palestinian Territory 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
PA - Panama 8
AM - Armenia 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
CR - Costa Rica 7
LB - Libano 7
SN - Senegal 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
A1 - Anonimo 5
MU - Mauritius 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BH - Bahrain 4
DK - Danimarca 4
GT - Guatemala 4
LK - Sri Lanka 4
LV - Lettonia 4
RS - Serbia 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
KW - Kuwait 3
MD - Moldavia 3
QA - Qatar 3
Totale 46.553
Salva come PNG Salva come JPEG
Città #
Singapore 2.437
Fairfield 2.179
Ashburn 1.928
Woodbridge 1.782
Jacksonville 1.540
Hong Kong 1.451
Houston 1.324
Chandler 1.119
The Dalles 956
Seattle 865
Cambridge 856
Ann Arbor 807
Wilmington 785
Beijing 754
Princeton 720
San Jose 688
New York 580
Nanjing 517
Lauterbourg 400
Dublin 389
Warsaw 382
Los Angeles 379
Brescia 376
Istanbul 374
Helsinki 331
Milan 298
Council Bluffs 251
Dallas 243
Munich 230
Ho Chi Minh City 217
Des Moines 187
Nanchang 185
Redondo Beach 174
São Paulo 171
Moscow 164
Changsha 163
Dearborn 154
Buffalo 152
Shenyang 138
Boardman 132
Lancaster 132
Tianjin 132
Jinan 127
Chicago 124
Hebei 124
Hanoi 121
Rome 121
Shanghai 114
San Diego 111
San Francisco 99
Orem 90
London 87
Santa Clara 83
Hangzhou 82
Jiaxing 80
Frankfurt am Main 79
Tokyo 76
Brno 71
Toronto 70
Turku 63
Zhengzhou 62
Brooklyn 61
Mexico City 61
Romola 60
Guangzhou 57
Rio de Janeiro 56
Belo Horizonte 54
Kunming 54
Nuremberg 51
Montreal 49
San Mateo 49
Johannesburg 48
Chennai 44
Tashkent 43
Washington 43
Stockholm 42
Denver 41
Abuja 40
Atlanta 40
Jakarta 40
Manchester 40
Brussels 37
Amsterdam 34
Augusta 34
Lanzhou 34
Phoenix 34
Salt Lake City 34
Turin 34
Verona 34
Mumbai 33
Ningbo 33
Norwalk 33
Boston 31
Haikou 31
Paris 31
Taizhou 31
Brasília 30
Orange 30
Porto Alegre 30
Düsseldorf 29
Totale 30.416
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 478
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 318
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 257
Il training cognitivo nei pazienti affetti da schizofrenia 240
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 237
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 226
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 218
Autism spectrum disorder and schizophrenia: Do they overlap? 206
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 206
Cognitive remediation in schizophrenia: current status and future perspectives. 200
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 193
Correlates of autistic traits among patients with borderline personality disorder 193
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 192
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 188
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia 187
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 187
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 185
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 183
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 183
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 182
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 180
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 177
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 175
Cognitive remediation in schizophrenia. 175
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 175
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 174
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 173
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 173
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 173
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 172
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 168
Autistic symptoms predict social cognitive performance in patients with schizophrenia 167
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 165
A roadmap to disentangle the molecular etiology of schizophrenia 164
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 163
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 162
Factors Associated With Brain Heterogeneity in Schizophrenia 161
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 160
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 159
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 157
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 157
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 156
Cognitive remediation in the early course of schizophrenia: a critical review. 156
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 155
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 155
Adherence to antipsychotics in schizophrenia. 154
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 154
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 154
A genome-wide search for schizophrenia susceptibility genes. 152
Cognitive remediation in schizophrenia: a controlled study 151
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 150
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 150
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 150
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 150
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy 150
Brain structural effects of antidepressant treatment in major depression 149
Tools for measuring clinical effectiveness. 147
Translation and Validation of Italian Version of Index of Dental Anxiety and Fear (IDAF-4C+): A Cross-Sectional Study 147
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 146
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 145
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 145
Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study 145
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 144
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 144
Season of birth and cerebral ventricular enlargement in schizophrenia 144
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 143
Age of onset in familial schizophrenia. 143
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 143
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 143
HLA-DR antigens in schizophrenia. 142
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 141
Fertility and marital status in mood disorders: relationship with age at onset. 141
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 140
Cortical atrophy in schizophrenia: prevalence and associated features 139
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 139
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 139
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 138
Uso della PET e della SPECT in psichiatria 138
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 138
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 138
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 138
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 137
CT scan abnormalities and outcome of chronic schizophrenia 137
Carlo Lorenzo Cazzullo (1915-2010): father of Italian psychiatry 137
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 137
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 136
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 136
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services 136
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 136
Magnetic resonance imaging findings in schizophrenia: relationships with language and thought disorders, symptomatology and cognitive performance. 135
Early life events and affective disorder revisited. 134
Disturbi psichici perinatali:focus sulla depressione post partum. 134
Il rimedio cognitivo nelle psicosi: principi e metodi. 134
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 134
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 134
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 133
A meta-analysis of quantitative magnetic resonance imaging study in first-episode schizophrenia. 133
The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia 132
Change in core symptoms of borderline personality disorder by tDCS: A pilot study 132
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 132
Totale 16.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.431 0 0 0 0 0 0 0 0 0 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20257.512 93 98 144 820 866 631 594 238 893 711 1.569 855
2025/202613.686 1.445 1.983 1.197 1.999 1.371 1.070 2.143 602 844 1.032 0 0
Totale 47.404